The Dual Pricing Scandal That Could Reshape Venture Capital
Mercor's Brendan Foody accuses Sequoia of dual pricing equity. This practice distorts valuations and raises questions about fairness in venture capital.
Last updated: June 9, 2026
Brendan Foody accused Sequoia of dual pricing, selling the same equity at different prices to different investors, distorting valuations and undermining transparency.
Brendan Foody, the CEO of AI talent marketplace Mercor, has thrown a grenade into the venture capital establishment. In a public statement covered by TechCrunch, Foody accused Sequoia Capital, one of the most prestigious firms in Silicon Valley, of engaging in what he calls a dual pricing scheme. The accusation is simple but damning: Sequoia allegedly sells the same equity in portfolio companies to different investors at two different prices. This practice, if confirmed, would undermine the foundational principle of transparency that underpins venture capital valuations.
The Mechanics of a Dubious Practice
Dual pricing is not a new concept, but its use in venture capital has remained largely in the shadows until now. Foody’s claim suggests that Sequoia offers a lower price to favored investors, such as large institutional funds or sovereign wealth funds, while charging a higher price to smaller or less connected investors for the same equity stake. The result is an artificial inflation of a company’s valuation, because the higher price is often the one reported to the public and to limited partners. This creates a distorted picture of a startup’s worth, benefiting the firm at the expense of transparency and fairness. Mercor’s accusation places a spotlight on a practice that many in the industry have suspected but few have dared to name publicly.
Why This Matters Beyond Sequoia
The implications of this accusation extend far beyond one firm. If dual pricing is a widespread practice, it calls into question the entire valuation ecosystem that startups rely on for fundraising, hiring, and strategic planning. Founders who accept money at an inflated valuation may face down rounds later, diluting their equity and damaging morale. Limited partners, the pension funds and endowments that supply capital to venture firms, could be misled about the true performance of their investments. For the broader technology industry, this erodes trust in the metrics that drive decisions, from M&A to IPO pricing. Foody’s decision to speak out may embolden other entrepreneurs and investors to demand greater accountability, potentially leading to regulatory scrutiny or industry-wide reforms.
What Comes Next for Venture Capital
The venture capital industry has long operated on a handshake culture where relationships often trump formal rules. This accusation challenges that culture head on. If Sequoia is forced to respond or if other firms are drawn into the controversy, we could see a shift toward more standardized reporting of deal terms. Regulators may take notice, especially as the SEC has already shown interest in private market transparency. For practitioners, the message is clear: due diligence must now include a deeper look at how valuations are constructed and who is paying what. The era of blind trust in top tier firms may be coming to an end. The next chapter will depend on whether Sequoia provides a credible defense or whether this becomes a catalyst for lasting change in how venture capital does business.
Source: TechCrunch AI
Frequently Asked Questions
What exactly is dual pricing in venture capital?
Dual pricing is when a venture firm sells the same equity in a portfolio company to different investors at two different prices. The higher price is often reported publicly, inflating the company's valuation.
Why did Brendan Foody call out Sequoia specifically?
Foody, as CEO of Mercor, publicly accused Sequoia of engaging in this practice to highlight what he sees as a systemic issue in venture capital. He chose Sequoia because of its prominence and influence in the industry.
What are the potential consequences for startups if dual pricing is confirmed?
Startups could face down rounds if their valuations are artificially inflated, hurting founder equity and employee morale. It also erodes trust with investors and may lead to stricter regulatory oversight.
